To further investigate the side effects of the novel mAbs with respect to those of ipilimumab and atezolizumab, we also evaluated the levels of Granzyme B, usually released by either cytotoxic CD8+ T cells or by natural killer (NK) cells to eliminate tumor cells. The gene discussed is CD8A; the disease is neoplasm.